SensiGen, LLC
SensiGen Receives Investment from Michigan Economic Development Corporation
Published in Law and Health Weekly, March 8th, 2008
SensiGen, LLC, a biotechnology company developing proprietary gene-based molecular diagnostics, announced that the Michigan Economic Development Corporation (MEDC), a nationally recognized state sponsored initiative to promote business formation, expansion, and retention in the State of Michigan, has approved an additional investment in SensiGen to be used for expanding SensiGen's operations in Ann Arbor. The investment, in the form of a term loan at 1% interest, will be used for hiring workers displaced by the closure of Pfizer's Michigan based research facilities as part of SensiGen's planned expansion of operations in the state.
"We are extremely fortunate to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AK Steel
U.S. Court Approves AK Steel's VEBA Health Care Settlement With Middletown Works Retirees - American Medical Association
AMA Foundation Honors Canton, Ohio Physician for Increasing Access to Health Care in the U.S. - American Medical Association
AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards - American Psychological Association
'Internet predator' stereotypes debunked in new study - American Society of Agronomy
Is it organic or not? - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley
Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
